PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations,
PACS developer Cemax is puttingthe regulatory pieces together for its line of image managementand archiving products. Cemax received Food and Drug Administration510(k) marketing clearance last month for its ClinicalView andDiagnosticView workstations, two of the products in the Fremont,CA, vendor's Perfect Vision series of display technology.
ClinicalView is a Sun-based display station designed for nurses,physicians and technologists at hospital locations outside theradiology department, such as emergency and critical care units.The workstation has a resolution of 1280 x 1600 on a 24-inch portraitmonitor.
DiagnosticView, also a Sun-based system, is a review stationwith 2000 x 2000-pixel resolution, 21-inch portrait monitors foruse by radiologists. Both workstations support Fuji and Du Pontcomputed radiography devices and interfaces with Lumisys and DuPont digitizers.
The display stations archive to 8-mm digital tape and aresupported by the company's ImageServer distributed image managementand archiving architecture. Cemax received FDA clearance for itsImageServer software last year (SCAN 12/29/93).
Cemax signed a joint sales and marketing agreement with 3Min February for the Perfect Vision products. 3M unveiled the Cemaxline as the 3M Image Management System at last month's AmericanInstitute of Ultrasound in Medicine meeting.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.